1st Quarter - Report

HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC for EMERGENT BIOSOLUTIONS

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

Further Consolidated Appropriations Act, 2024 - Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and stockpiling of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; H.R. 3935 - Securing Growth and Robust Leadership in American Aviation Act - Section 527 - Emergency Medical Equipment on Passenger Aircraft; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; State opioid response (SOR) grant funding proposals; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; Draft - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.

LobbyistCovered position, as disclosed
TIMOTHY P HECHT —
THOMAS PAUL LATHAM —
FRANKLIN C PHIFER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6243 (118th), H.R. 3935 (118th), H.R. 4421 (118th), S. 2333 (118th)

Disaster Planning/Emergencies DIS

Further Consolidated Appropriations Act, 2024 - Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and stockpiling of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; H.R. 3935 - Securing Growth and Robust Leadership in American Aviation Act - Section 527 - Emergency Medical Equipment on Passenger Aircraft; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; State opioid response (SOR) grant funding proposals; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; Draft - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.

LobbyistCovered position, as disclosed
TIMOTHY P HECHT —
THOMAS PAUL LATHAM —
FRANKLIN C PHIFER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2333 (118th), H.R. 4421 (118th), H.R. 6243 (118th), H.R. 3935 (118th)

Budget/Appropriations BUD

Further Consolidated Appropriations Act, 2024 - Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and stockpiling of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; State opioid response (SOR) grant funding proposals; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs and funding; Draft - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.

LobbyistCovered position, as disclosed
TIMOTHY P HECHT —
THOMAS PAUL LATHAM —
FRANKLIN C PHIFER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2333 (118th), H.R. 4421 (118th)

Health Issues HCR

Further Consolidated Appropriations Act, 2024 - Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and stockpiling of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; H.R. 3935 - Securing Growth and Robust Leadership in American Aviation Act - Section 527 - Emergency Medical Equipment on Passenger Aircraft; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; State opioid response (SOR) grant funding proposals; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; Draft - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.

LobbyistCovered position, as disclosed
TIMOTHY P HECHT —
THOMAS PAUL LATHAM —
FRANKLIN C PHIFER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2333 (118th), H.R. 3935 (118th), H.R. 6243 (118th), H.R. 4421 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.